Table 2.

Comparison of infectious diseases outcome between statin-users and non-users

Infection	Statin-Users (n=12,981)	Non-Users (n=32,266)	Adjusted OR (95% CI) *
	n (%)	n (%)
Common infections group	8,939 (68.9)	19,323 (59.9)	1.13 (1.06–1.19)
Influenza	145 (1.1)	307 (0.9)	1.06 (0.80–1.39)
Fungal infections	3,171 (24.4)	5,667 (17.6)	0.97 (0.91–1.04)

^*Logistic regression analysis; covariates were patient age, patient gender, total Charlson Comorbidity Score, tobacco use, alcohol use/abuse, number of inpatient admissions in the baseline period, number of outpatient admissions in the baseline period, and use of the following medications: beta-blockers, diuretics, calcium-channel blockers, ACE inhibitors/ARBs, oral hypoglycemics, aspirin, and steroids.

OR=odds ratio, CI=confidence interval